Concepedia

Author

Didier Heumann

University Hospital of Lausanne

Also Known As

Cambridge Vogt, D HEUMANN, D Heumann, D. HEUMANN, D. Heumann, DIDIER HEUMANN, Didier Heumann

105

Publications

7.1K

Citations

38

H-Index

115

Concepts

All Affiliations

University Hospital of LausanneUniversity of LausanneLudwig Cancer ResearchHôpital Orthopédique de la Suisse RomandeRoche (Switzerland)
DH

About

Didier Heumann is an author at University Hospital of Lausanne specializing in medicine, immunology, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

39

4.2K

2

Allergy

6

6

665

3

Social Sciences

3

3

154

4

Health Sciences

2

2

126

5

Natural Sciences

2

2

175

Didier Heumann

×

63

Publications

6.4K

Citations

36

H-Index

YearCitations

Protection from septic shock by neutralization of macrophage migration inhibitory factor

Thierry Calandra, Bernd Echtenacher, Didier Le Roy,

Nature Medicine

2000

721

CD14 Is a pattern recognition receptor

Jérôme Pugin, Didier Heumann, Alexander Tomasz,

Immunity

1994

705

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

Thierry Calandra, J. Gérain, Didier Heumann,

The American Journal of Medicine

1991

447

Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations

Isabelle de Werra, C Jaccard, Sally Betz Corradin,

Critical Care Medicine

1997

392

Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes

Didier Heumann, C Barras, A Severin,

Infection and Immunity

1994

342

Interferon gamma receptor deficient mice are resistant to endotoxic shock.

Bruce D. Car, Vicki M. Eng, Bruno Schnyder,

The Journal of Experimental Medicine

1994

293

Cathelicidin Family of Antibacterial Peptides CAP18 and CAP11 Inhibit the Expression of TNF-α by Blocking the Binding of LPS to CD14+ Cells

Isao Nagaoka, François Niyonsaba, Michimasa Hirata,

The Journal of Immunology

2001

260

Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide

Gláucia Zanetti, Didier Heumann, J. Gérain,

The Journal of Immunology

1992

247

Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes

Didier Heumann, Philippe Gallay, C Barras,

The Journal of Immunology

1992

213

Augmentation of the Lipopolysaccharide-Neutralizing Activities of Human Cathelicidin CAP18/LL-37-Derived Antimicrobial Peptides by Replacement with Hydrophobic and Cationic Amino Acid Residues

Isao Nagaoka, François Niyonsaba, Michimasa Hirata,

Clinical and Vaccine Immunology

2002

161

Page 1